Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

MLA

Carson, Kenneth R., et al. “Progressive Multifocal Leukoencephalopathy Associated with Brentuximab Vedotin Therapy: A Report of 5 Cases from the Southern Network on Adverse Reactions (SONAR) Project.” Cancer (0008543X), vol. 120, no. 16, Aug. 2014, pp. 2464–71. EBSCOhost, https://doi.org/10.1002/cncr.28712.

APA

Carson, K. R., Newsome, S. D., Kim, E. J., Wagner, J. N. D., Geldern, G., Moskowitz, C. H., Moskowitz, A. J., Rook, A. H., Jalan, P., Loren, A. W., Landsburg, D., Coyne, T., Tsai, D., Raisch, D. W., Norris, L. B., Bookstaver, P. B., Sartor, O., & Bennett, C. L. (2014). Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer (0008543X), 120(16), 2464–2471. https://doi.org/10.1002/cncr.28712

Chicago

Carson, Kenneth R., Scott D. Newsome, Ellen J. Kim, Johnston, Nina D. Wagner, Gloria Geldern, Craig H. Moskowitz, Alison J. Moskowitz, et al. 2014. “Progressive Multifocal Leukoencephalopathy Associated with Brentuximab Vedotin Therapy: A Report of 5 Cases from the Southern Network on Adverse Reactions (SONAR) Project.” Cancer (0008543X) 120 (16): 2464–71. doi:10.1002/cncr.28712.